Al di là della perdita di peso: potere metabolico e immunologico degli agonisti del GLP-1 nella chirurgia plastica

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used for glycemic control and weight management in patients with type 2 diabetes and obesity, and their use has become increasingly common among candidates for elective plastic surgery. As a result, plastic surgeons are frequently encountering patients receiving GLP-1 RA therapy in the setting of metabolic and inflammatory comorbidities that may influence perioperative risk. This focused review examines the existing literature on GLP-1 RAs and contextualizes their biologic effects with considerations relevant to elective plastic surgery. A review of studies identified through PubMed, MEDLINE, and ClinicalKey was performed, with